IGFBP3 Antikörper
-
- Target Alle IGFBP3 Antikörper anzeigen
- IGFBP3 (Insulin-Like Growth Factor Binding Protein 3 (IGFBP3))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGFBP3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Immunogen
- insulin-like growth factor binding protein 3
- Isotyp
- IgG
- Top Product
- Discover our top product IGFBP3 Primärantikörper
-
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (Internal Region) antibody
IGFBP3 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 186-292) antibodyIGFBP3 Reaktivität: Human, Ratte WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 162-189) antibodyIGFBP3 Reaktivität: Human, Maus, Hamster WB Wirt: Kaninchen Polyclonal RB28430 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 101-210) antibodyIGFBP3 Reaktivität: Human WB, IF Wirt: Maus Monoclonal 4-IGFBP unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 182-291) antibodyIGFBP3 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2G6 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 152-292) antibodyIGFBP3 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 135-277) antibodyIGFBP3 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal D10 unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 137-274) antibodyIGFBP3 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (AA 106-241) antibodyIGFBP3 Reaktivität: Rind (Kuh) WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) (Ser53) antibodyIGFBP3 Reaktivität: Human, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
A2780 cells were subjected to SDS PAGE followed by western blot with FNab04178(IGFBP3 antibody) at dilution of 1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze / thaw cycles.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
- Target
- IGFBP3 (Insulin-Like Growth Factor Binding Protein 3 (IGFBP3))
- Andere Bezeichnung
- IGFBP3 (IGFBP3 Produkte)
- Synonyme
- BP-53 antikoerper, IBP3 antikoerper, AI649005 antikoerper, IGFBP-3 antikoerper, IGgfbp3 antikoerper, IGF-BP3 antikoerper, zgc:91788 antikoerper, IGFBP3 antikoerper, igfbp3 antikoerper, insulin like growth factor binding protein 3 antikoerper, insulin-like growth factor binding protein 3 antikoerper, IGFBP3 antikoerper, Igfbp3 antikoerper, igfbp3 antikoerper, IGFBP-3 antikoerper, LOC100305016 antikoerper
- Hintergrund
- Synonyms:BP 53, IBP 3, IBP3, IGF binding protein 3, IGFBP 3, IGFBP3 Background:IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Also exhibits IGF-independent antiproliferative and apoptotic effects mediated by its receptor TMEM219/IGFBP-3R.
- Molekulargewicht
- 37-45 kDa
- Gen-ID
- 3486
- UniProt
- P17936
- Pathways
- Myometrial Relaxation and Contraction, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagie, Smooth Muscle Cell Migration, Growth Factor Binding
-
